Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis

scientific article published on 22 August 2019

Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41398-019-0534-2
P932PMC publication ID6706374
P698PubMed publication ID31439831

P50authorPhilip McGuireQ37834611
Sagnik BhattacharyyaQ43272523
Elizabeth Appiah-KusiQ57614927
Natalia PetrosQ92796974
P2093author name stringMichael Brammer
Jesus Perez
Paul Allen
Robin Wilson
Matthijs G Bossong
P2860cites workOpposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathologyQ24602238
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophreniaQ24607361
Translating the MAM model of psychosis to humansQ26860217
Dissociable intrinsic connectivity networks for salience processing and executive controlQ28290658
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamideQ28362078
A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networksQ29619139
Saliency, switching, attention and control: a network model of insula functionQ29619521
Aberrant coupling within and across the default mode, task-positive, and salience network in subjects at risk for psychosisQ30387810
Symptom dimensions are associated with reward processing in unmedicated persons at risk for psychosisQ30390106
Anterior cingulate volumes in schizophrenia: a systematic review and a meta-analysis of MRI studiesQ31107763
Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophreniaQ33963430
Systematic meta-analysis of insula volume in schizophreniaQ34279283
Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication.Q34295212
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairmentQ34304341
Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental StatesQ34475129
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging studyQ36928703
Reduced Brain Cannabinoid Receptor Availability in SchizophreniaQ36945634
The nature of dopamine dysfunction in schizophrenia and what this means for treatmentQ37062793
Neural and behavioral correlates of aberrant salience in individuals at risk for psychosisQ37228333
Altered Insular Function during Aberrant Salience Processing in Relation to the Severity of Psychotic SymptomsQ37430456
Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis.Q37563725
A review of reward processing and motivational impairment in schizophreniaQ37602601
Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driverQ37665156
Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS studyQ37711762
Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunctionQ37892677
Dopaminergic basis of salience dysregulation in psychosisQ38175606
Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophreniaQ38466601
Dopamine reward prediction-error signalling: a two-component responseQ38728913
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptorQ38848638
Ventral Striatal Activation During Reward Processing in Psychosis: A Neurofunctional Meta-AnalysisQ40332969
Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort.Q42519170
Follow-up MRI study of the insular cortex in first-episode psychosis and chronic schizophreniaQ45027787
Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosisQ45758350
Altered activation and connectivity in a hippocampal-basal ganglia-midbrain circuit during salience processing in subjects at ultra high risk for psychosisQ45839278
Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine releaseQ46182958
Modulation of motivational salience processing during the early stages of psychosisQ47649698
Cortical salience network activation precedes the development of delusion severityQ47980947
Alterations of the brain reward system in antipsychotic naïve schizophrenia patientsQ48002568
Motivation and movement: the effect of monetary incentive on performance speedQ48152477
Ventral striatal activation during reward processing in subjects with ultra-high risk for schizophrenia.Q48439772
Salience processing and insular cortical function and dysfunctionQ48453343
Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia.Q48481384
Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals.Q49061063
Resting Hyperperfusion of the Hippocampus, Midbrain, and Basal Ganglia in People at High Risk for PsychosisQ49126675
FMRI visualization of brain activity during a monetary incentive delay task.Q52167219
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.Q52750107
Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of PsychosisQ57403237
The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task.Q60630987
Dysconnectivity of Large-Scale Functional Networks in Early Psychosis: A Meta-analysisQ60640855
The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trialQ88271142
Prolonged Psychosis Associated with Left Insular Stroke: Talking to God in the WallsQ88644336
P433issue1
P921main subjectpsychosisQ170082
P304page(s)203
P577publication date2019-08-22
P1433published inTranslational PsychiatryQ15716636
P1476titleCannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis
P478volume9

Reverse relations

cites work (P2860)
Q99402872A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis
Q96303345Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition

Search more.